The Optimized Protocol of Hyperbaric Oxygen Therapy For Sudden Sensorineural Hearing Loss. (12th May 2022)

• Record Type: Journal Article
• Authors: Kim, Hwabin; Kong, Soo‐Keun; Kim, Jia; Lee, Hyun‐Min; Choi, Sung‐Won; Lee, Il‐Woo; Oh, Se‐Joon
• Is Part Of: Laryngoscope. Volume 133:Number 2(2023)
• Page Start: 383
• Page End: 388
• Publication Date: 2022-05-12
• Subjects: hyperbaric oxygen therapy -- intratympanic injection -- sudden sensorineural hearing loss -- systemic steroid -- treatment; Otolaryngology -- Periodicals; 617.51005
• DOI: 10.1002/lary.30181
• Languages: English
• ISSNs: 0023-852X

Abstract

Abstract : Objective: This study aimed to determine the optimal protocol of hyperbaric oxygen therapy (HBOT) according to various treatment settings for sudden sensorineural hearing loss (SSNHL). Methods: A 112 patients with SSNHL were enrolled in this prospective study. All patients were treated with systemic steroid therapy, intratympanic steroid therapy, and HBOT. According to the pressure and duration of HBOT (10 sessions in total), the patients were divided into three groups: group 1, 2.5 atmospheres absolute (ATA) for 1 h; group 2, 2.5 ATA for 2 h; and group 3, 1.5 ATA for 1 h. The pure‐tone average (PTA), word discrimination score (WDS), and mean gain were compared. Results: A total of 105 patients completed the 3‐month follow‐up, and 6 patients were excluded. Differences among groups were found in PTA, WDS, and mean gain. In the post‐hoc analysis, group 3 had significantly lower WDS and mean gain than groups 1 and 2; however, group 2 showed no significant differences from group 1. The proportion of patients with hearing recovery after treatment was significantly higher in group 1 (57.6%) and group 2 (58.8%) than in group 3 (31.3%). Conclusions: When HBOT (10 sessions) was combined with corticosteroids as the initial therapy for SSNHL, a higher pressure (1.5 ATA vs. 2.5 ATA) provided better treatment results; however, increasing the duration (1 h vs. 2 h) under 2.5 ATA did not result in a significant difference. Therefore, HBOT for SSNHL may be performed at 2.5 ATA for 1 h in 10 sessions. Laryngoscope, 133:383–388, 2023 Abstract : When HBOT (10 sessions) was combined with corticosteroids as the initial therapy for SSNHL, a higher pressure (1.5 ATA vs. 2.5 ATA) provided better treatment result; however, increasing the duration (1 h vs. 2 h) did not result in a significant difference. The addition of 1.5 ATA HBOT showed similar results to the treatment without HBOT in our previous study.